ong-Term Study of CN-801 in patients with idiopathic hypersomnia
Phase 3
- Conditions
- Idiopathic hypersomnia
- Registration Number
- JPRN-jRCT2080222564
- Lead Sponsor
- Alfresa Pharma Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Patients diagnosed with idiopathic hypersomnia based on the International Classification of Sleep Disorders, second edition (ICSD-2) and who have completed the preceding double-blind comparative study
Exclusion Criteria
Patients with narcolepsy, restless legs syndrome, periodic limb movement disorder, or sleep apnea syndrome
Patients working irregular shifts or night shifts
Patients with chronic sleep deprivation or patients with extremely irregular bed times
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safty, Efficacy (Japanese version of the Epworth Sleepiness Scale)
- Secondary Outcome Measures
Name Time Method